290 related articles for article (PubMed ID: 31781842)
21. Dysfunctional T cell metabolism in the tumor microenvironment.
Beckermann KE; Dudzinski SO; Rathmell JC
Cytokine Growth Factor Rev; 2017 Jun; 35():7-14. PubMed ID: 28456467
[TBL] [Abstract][Full Text] [Related]
22. Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review).
Yu XH; Ren XH; Liang XH; Tang YL
Mol Med Rep; 2018 Dec; 18(6):5307-5316. PubMed ID: 30365095
[TBL] [Abstract][Full Text] [Related]
23. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
24. Emerging approaches to target tumor metabolism.
Ross SJ; Critchlow SE
Curr Opin Pharmacol; 2014 Aug; 17():22-9. PubMed ID: 25048629
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer.
Shevchenko I; Bazhin AV
Front Immunol; 2018; 9():1816. PubMed ID: 30131808
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
27. Dendritic Cell Metabolism and Function in Tumors.
Giovanelli P; Sandoval TA; Cubillos-Ruiz JR
Trends Immunol; 2019 Aug; 40(8):699-718. PubMed ID: 31301952
[TBL] [Abstract][Full Text] [Related]
28. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
Pacella I; Piconese S
Front Immunol; 2019; 10():1889. PubMed ID: 31507585
[TBL] [Abstract][Full Text] [Related]
29. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
30. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.
Vigano S; Alatzoglou D; Irving M; Ménétrier-Caux C; Caux C; Romero P; Coukos G
Front Immunol; 2019; 10():925. PubMed ID: 31244820
[TBL] [Abstract][Full Text] [Related]
31. Oxidative Phosphorylation as an Emerging Target in Cancer Therapy.
Ashton TM; McKenna WG; Kunz-Schughart LA; Higgins GS
Clin Cancer Res; 2018 Jun; 24(11):2482-2490. PubMed ID: 29420223
[TBL] [Abstract][Full Text] [Related]
32. Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.
Evrard D; Szturz P; Tijeras-Raballand A; Astorgues-Xerri L; Abitbol C; Paradis V; Raymond E; Albert S; Barry B; Faivre S
Oral Oncol; 2019 Jan; 88():29-38. PubMed ID: 30616794
[TBL] [Abstract][Full Text] [Related]
33. Emerging Opportunities and Challenges in Cancer Immunotherapy.
Whiteside TL; Demaria S; Rodriguez-Ruiz ME; Zarour HM; Melero I
Clin Cancer Res; 2016 Apr; 22(8):1845-55. PubMed ID: 27084738
[TBL] [Abstract][Full Text] [Related]
34. The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.
DeRosa A; Leftin A
Front Immunol; 2021; 12():614294. PubMed ID: 33986740
[TBL] [Abstract][Full Text] [Related]
35. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
Setrerrahmane S; Xu H
Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
[TBL] [Abstract][Full Text] [Related]
36. Novel strategies for cancer therapy.
Semenza GL
J Mol Med (Berl); 2016 Feb; 94(2):119-20. PubMed ID: 26780330
[No Abstract] [Full Text] [Related]
37. Anti-CCR5 Therapy Circumvents Immune Cell Exploitation by Tumors.
Cancer Discov; 2016 Jun; 6(6):571. PubMed ID: 27125549
[TBL] [Abstract][Full Text] [Related]
38. Leukocyte trafficking: Can we bring the fight to the tumor?
Pachynski R; Nazha J; Kohrt H
Discov Med; 2016 Mar; 21(115):205-12. PubMed ID: 27115171
[TBL] [Abstract][Full Text] [Related]
39. Tumor Metabolism as a Regulator of Tumor-Host Interactions in the B-Cell Lymphoma Microenvironment-Fueling Progression and Novel Brakes for Therapy.
Beielstein AC; Pallasch CP
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454887
[TBL] [Abstract][Full Text] [Related]
40. [Metabolic Competition in Tumor Microenvironment].
Eikawa S; Udono H
Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
